Podcasts
Listen to Avalere Health Essential Voice podcasts. Twenty years ago, we set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to hear our experts discuss the hot topics that you need to track.
E10, Part 1 – Get the Facts on COVID-19: Impacts on Healthcare Provider Performance
Tune into the tenth episode of our series of podcasts that focuses on COVID-19, which will discuss impacts on provider performance in 3 critical segments. In episode 10 Part I, Avalere experts from the Center for Healthcare Transformation will discuss the impacts of COVID-19 on measures, specifically related to cardiovascular disease, diabetes, obstetrics and gynecology, and primary care disease management.
E3 – Start Your Day with Avalere: Translating Clinical Evidence to Value
In this third episode, Sam Ferguson, a consultant in Avalere’s Market Access practice, along with Allison Petrilla, a managing director in Avalere’s Health Economics and Advanced Analytics practice, and Amy Schroeder, a senior consultant in Avalere’s Market Access practice, discuss how stakeholders are utilizing and translating real-world evidence (RWE) into value for oncology.
E2 – Start Your Day with Avalere: Understanding Payment for Durable Therapies
In the second episode, Sam Ferguson and Michael Kearney, consultants in Avalere’s Market Access practice, along with Megan Olsen, an associate principal in Avalere’s Policy practice, will discuss how to appropriately define the value of durable therapies in oncology and how to pay for those therapies within our current healthcare system.
E1 – Start Your Day with Avalere: Defining Value in Oncology
In the first episode, Sam Ferguson and Biruk Bekele, consultants in Avalere’s Market Access practice, along with Milena Sullivan, a principal in Avalere’s Policy practice, will discuss how stakeholders are defining value in oncology.
E4 – Specialty Pharmacy Stakeholder Perspectives: COVID-19 Business Impacts
In the fourth episode of the Specialty Pharmacy Stakeholder Perspectives podcast series, Avalere is joined by Adam Hanauer, Associate Vice President at Humana Specialty Pharmacy, and Mark Sasala, Principal Business Analyst of Products at Creehan & Company, to discuss the outlook of specialty pharmacy with a focus on the environmental considerations and potential impacts of COVID-19.
E3 – Specialty Pharmacy Stakeholder Perspectives: Provider Outlook & Market Access
In the third episode of the Specialty Pharmacy Stakeholder Perspectives podcast series, Avalere is joined by Dr. Colin Edgerton to discuss the specialty pharmacy dynamics with a focus on the provider outlook.
E2 – Specialty Pharmacy Stakeholder Perspectives: Patient Outlook
In the second episode of the Specialty Pharmacy Stakeholder Perspectives series, Avalere is joined by Marc Boutin, CEO of the National Health Council, discussing the specialty pharmacy dynamics with a focus on the patient perspective.
E9 – Get the Facts on COVID-19: Alternative Payment Model Impacts
Tune into the ninth episode of our podcast series, Get the Facts on COVID-19. In episode 9, Avalere experts from the Health Plans and Providers practice and the Center for Healthcare Transformation discuss the near- and long-term impacts of COVID-19 on value-based contracting and Alternative Payment Models (APMs). The conversation focuses on Medicare programs, such as specialty Accountable Care Organizations (ACOs) and bundled payment models, and newer Center for Medicare and Medicaid Innovation (CMMI) programs.
E1 – Specialty Pharmacy Stakeholder Perspectives: Specialty Pharmacy Outlook
In the first episode of the Specialty Pharmacy Stakeholder Perspectives series, Avalere is joined by Joel Wright, CEO at AllianceRx and Ernie Shopes, SVP Products and Client Delivery at Creehan and Company, discussing the outlook for specialty pharmacy, including a focus on trends in the pipeline and overall landscape.
E8 – Get the Facts on COVID-19: The Pharmacy Business
Tune into the eighth episode of our series of podcasts that focuses on COVID-19. In episode 8, Avalere experts from the Policy practice discuss the impact of COVID-19 pandemic on retail pharmacy and pharmacists.
E7 – Get the Facts on COVID-19: Post-Acute Care
Tune into the seventh episode of our series that focuses on COVID-19. In episode 7, Avalere experts from the Health Plans and Provider’s practice discuss the short- and long-term implications for post-acute care as a result of COVID-19.
E6 – Get the Facts on COVID-19: Oncology Care and Delivery
Avalere experts discuss how the COVID-19 pandemic has affected oncology care and delivery, and the Oncology Care Model (OCM).
E5 – Get the Facts on COVID-19: The Healthcare Landscape and Policy Debate
Tune into the fifth episode of our series that focuses on COVID-19. In episode 5, Avalere experts from the Policy practice discuss how COVID-19 has impacted the healthcare landscape and policy debate.
E4 – Get the Facts on COVID-19: The Future of Healthcare Delivery
In the fourth episode of this series, Avalere experts discuss the impact of the COVID-19 pandemic on care delivery and the future of telehealth.
E3 – Get the Facts on COVID-19: A Comparison to Other Outbreaks
In the third episode of this series, Avalere experts discuss how the COVID-19 pandemic and response compares to previous outbreaks.
E2 – Get the Facts on COVID-19: Patient Out-of-Pocket Costs
Tune into the second episode of our podcast series that focuses on COVID-19. In episode 2, Avalere experts discuss how Medicare, Medicaid, and commercial plans will address the patient out of pocket costs associated with COVID-19 testing and treatment. They also acknowledge how commercial manufacturers are addressing the shortage of tests and turnaround for COVID-19 testing in the US.
E1 – Get the Facts on COVID-19: Vaccination Affordability and Access
Tune in to hear the first episode of our podcast series that focuses on COVID-19. In this episode, Avalere experts will discuss COVID-19 vaccinations, focusing on the timeline of development, affordability, and access.
E3 – Avalere Insights on Recent CMS Proposed Payment Rules: ESRD PPS and Quality Incentive Program
Tune in to hear the final episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 3, we’ll be focusing on the End Stage Renal Disease (ESRD) Prospective Payment System, with a focus on proposed payment changes for innovative drugs, supplies, and equipment and updates to the Quality Incentive Program (QIP).
E2 – Avalere Insights on Recent CMS Proposed Payment Rules: MPFS
Tune in to hear the second episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 2, we’ll be focusing on the Medicare Physician Fee Schedule proposed rule, or MPFS, with a focus on proposed changes to E/M and Opioid Use Disorder (OUD) treatment services.
E1 – Avalere Insights on Recent CMS Proposed Payment Rules: OPPS
Tune in to hear the first episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 1, we’ll be focusing on the outpatient prospective payment system proposed rule, more informally known as the OPPS.
